Wavelength Effect in Laser Therapy of Diabetic Rats on Oxidants: AGEs, AOPP, ox-LDL Levels
Hossein Mirmiranpour,
Ahmad Amjadi,
Salile Khandani,
Yasaman Shafaee,
Seyed Omid Sobhani
Issue:
Volume 6, Issue 2, March 2020
Pages:
17-24
Received:
26 March 2020
Accepted:
21 April 2020
Published:
28 May 2020
Abstract: In Low-Level Laser Therapy (LLLT) choosing the proper laser wavelength is extremely important. In this article, we have investigated the effects of four different laser wavelengths on oxidant parameters (AGE, AOPP, and ox-LDL) levels in diabetic Wistar rats experimentally. At first, 24 rats were divided into six equal groups. Except for the none diabetic control group, the other five groups received streptozotocin (STZ) injection to induce diabetes. Four groups of diabetic rats were then irradiated by four different laser wavelengths IR (808nm), Red (638nm), Green (532nm) and Blue (450nm). The last group which did not receive any irradiation is named non-irradiated diabetic control group. Laser therapies were performed Intravenously through an animal's caudal vein by a fiber Optics. Finally, the levels of oxidant parameters in rat's blood samples of each group were discussed. Results show a decrease in oxidants levels in all four irradiated groups of rats relative to the non-irradiated diabetic control group. More importantly, shorter wavelengths affect more efficient than longer wavelengths on reducing the oxidants levels with constant Laser energy. As a result, we conclude that laser with shorter wavelength e.g. Blue is more effective than longer wavelengths e.g. IR or Red, in reducing the oxidant parameters (AGE, AOPP, and ox-LDL) levels in Intravenous LLLT.
Abstract: In Low-Level Laser Therapy (LLLT) choosing the proper laser wavelength is extremely important. In this article, we have investigated the effects of four different laser wavelengths on oxidant parameters (AGE, AOPP, and ox-LDL) levels in diabetic Wistar rats experimentally. At first, 24 rats were divided into six equal groups. Except for the none di...
Show More
Myofibroblastic Inflammatory Bowel Tumor: Unusual location, Case Report
Khalid Gharbi,
Mohammed Amine Lkousse,
Jamal Atmani,
Younes Ismail,
Abdeltif Elfarouki,
Adil Ait Errami Adil Ait Errami,
Sofia Oubaha,
Zohor Samlani,
Khadija Krati
Issue:
Volume 6, Issue 2, March 2020
Pages:
25-27
Received:
15 January 2020
Accepted:
10 February 2020
Published:
4 June 2020
Abstract: Inflammatory myofibroblastic tumours (IMT) are unusual benign tumours, also known as inflammatory pseudotumours, represent a group of fibro-inflammatory lesions of recent individualization. They are mesenchymal tumours of intermediate class, very rare and of unknown etiology. They are initially described in the lungs, but have been observed in several other locations, mainly abdominal and pelvic. Its location in the colon is exceptional. The evolutionary doubt of these tumours requires regular and long term follow-up. We report the case of a 30-year-old patient who presented with a stenosing caecal mass. After surgical removal, histological and immunohistochemical examination was in favor of a colonic (IMT). The clinical, radiological and histological characteristics of this anatomoclinical entity will be discussed in light of the data in the literature.
Abstract: Inflammatory myofibroblastic tumours (IMT) are unusual benign tumours, also known as inflammatory pseudotumours, represent a group of fibro-inflammatory lesions of recent individualization. They are mesenchymal tumours of intermediate class, very rare and of unknown etiology. They are initially described in the lungs, but have been observed in seve...
Show More
